OR1D5: Potential Drug Target Or Biomarker (G8386)
OR1D5: Potential Drug Target Or Biomarker
OR1D5 (OR1D5_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and muscle. It is a member of the OR1D family of proteins, which are known for their role in intracellular signaling. While the exact function of OR1D5 is not yet fully understood, research has shown that it is involved in a number of important cellular processes, including cell signaling, metabolism, and inflammation. As a potential drug target or biomarker, OR1D5 is of interest to researchers because it is thought to play a key role in the development and progression of a number of diseases, including cancer, obesity, and neurodegenerative disorders.
One of the key functions of OR1D5 is its role in intracellular signaling. OR1D5 is a member of the OR1D family of proteins, which are known for their ability to regulate protein-protein interactions and to participate in intracellular signaling pathways. These proteins are involved in a wide range of cellular processes, including cell signaling, metabolism, and inflammation. OR1D5 is thought to be involved in the regulation of these processes by interacting with other proteins, including Retinoblastoma gene (RB) 1 (p53), which is a well-known tumor suppressor gene that is involved in a number of cellular processes, including cell signaling and metabolism.
In addition to its role in intracellular signaling, OR1D5 is also involved in the regulation of cellular processes related to metabolism and energy homeostasis. OR1D5 is thought to be involved in the regulation of the levels of acetyl-CoA in the mitochondria, which is a critical nutrient for cellular energy production. It is also involved in the regulation of the levels of glucose in the blood, which is important for maintaining cellular energy homeostasis.
In addition to its role in metabolism, OR1D5 is also involved in the regulation of cellular processes related to inflammation. OR1D5 is a known regulator of the immune response, and it is thought to play a key role in the regulation of inflammation and autoimmune diseases. It is also involved in the regulation of inflammation-related signaling pathways, including the production of pro-inflammatory cytokines.
As a potential drug target or biomarker, OR1D5 is of interest to researchers because it is thought to play a key role in the development and progression of a number of diseases, including cancer, obesity, and neurodegenerative disorders. For example, OR1D5 has been shown to be involved in the regulation of cellular processes that are associated with the development of cancer, including the regulation of cell division and the production of pro-inflammatory cytokines. It is also thought to play a key role in the regulation of obesity, as it is involved in the regulation of cellular processes related to energy homeostasis. In addition, OR1D5 is also thought to be involved in the regulation of cellular processes that are associated with neurodegenerative disorders, including the regulation of neurotransmitter synthesis and the production of pro-inflammatory cytokines.
In conclusion, OR1D5 is a protein that is expressed in various tissues of the human body and is involved in a number of important cellular processes, including intracellular signaling, metabolism, and inflammation. As a potential drug target or biomarker, OR1D5 is of interest to researchers because it is thought to play a key role in the development and progression of a number of diseases, including cancer, obesity, and neurodegenerative disorders. Further research is needed to fully understand the role of OR1D5 in these processes and its potential as a drug target or biomarker.
Protein Name: Olfactory Receptor Family 1 Subfamily D Member 5
Functions: Odorant receptor
The "OR1D5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR1D5 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1
